FemiLift Studies

 

Treatment Graphs

Case 1 – one treatment

58-no-children-using-only-vaginal-low-dose-hormones-1-treatment

 

 

 

 

Case 2 – 1 treatment

58-years-no-children-using-vaginal-hormones-only-1-treatment

Case 3 – two treatments
58-year-old-one-vaginal-delivery-on-hrt

 Case 4 – 1 treatment of 3

50-years-on-hrt-three-vaginal-deliveries-one-treatment-of-three-recommended

 

 

Case 5 – 2 treatments

50-g2p3-hrt-and-very-active-2-treatments

Case 6 – one treatment


50-years-on-hrt-three-vaginal-deliveries-one-treatment-of-three-recommended

 Case 7

femilift-post-treatment-comments

From the desk of Dr. Maria (Lizette) Lourens

Dear Colleague:

As a physician specializing in women’s health, I have an increasing number of female patients presenting with urinary incontinence, vaginal dryness or laxity issues which negatively impact their quality of life and social interactions. It’s a common problem as urinary incontinence affects approximately 33% of women ages 41 – 64, increasing to 55% of women over the age of 65.

To aid in treatment of my female patients, I have purchased a highly effective, non-surgical vaginal rejuvenation treatment, FemiLift. FemiLift utilizes a C02 laser, technology that has been in use for the past 30 years and has proven to be safe and effective for many applications, including gynecology.

Within my medical practice, I have experienced excellent results using FemiLift for women experiencing:

  • Bladder leakage
  • Stress urinary incontinence
  • Urgency incontinence
  • Vaginal laxity
  • Vaginal dryness
  • Painful sex (due to vaginal dryness)

FemiLift treatment demonstrates effectiveness to treat and cure incontinence disorders by a percentage similar to TVT surgery in patients without or with minimal damage to the pelvic floor. Based on clinical experience with FemiLift, about 90% of patients show a good response after 2-3 treatments for urinary incontinence. For treatment for vaginal dryness and laxity, many patients require just one treatment.

Unfortunately, the FemiLift laser treatment is not covered by Alberta Health Care. However, it’s important to note that studies have shown an individual living with incontinence will spend $1,400 – $2,100 per year on products to manage their incontinence. By comparison, the cost of FemiLift is a good investment and much better for quality of life. Additionally, patients are reminded the cost may be claimed as a medical expense when filing their taxes.

The increase in life expectancy and the changes in social, work and sexual activities during the fifth decade of life and beyond are transforming the issues of urinary incontinence and vaginal health challenges into a true epidemic.

If you wish to have some brochures on FemiLift to distribute to patients who might be interested, please email Connie at hormones@calgaryagemanagement.com and we will have some mailed to you immediately.

There is also additional information here on our website for patients, and we welcome them to self refer for a complimentary consultation.

Kind Regards,

Dr Lizette signature

 

 

Dr. Maria E. (Lizette) Lourens,, M.D.,CCFP, FCFP, FAARM

Age Management Institute in Calgary and Canmore